Main sector:
Pharma (fully integrated)
Subsectors:
Antibodies
Anti-infectives
Biosimilars
Cell therapy
Drug delivery
Gene therapy
Nucleic acid drugs
Small molecule therapeutics
Immunotherapy
Indications:
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 95
On the market: 36
Description:
Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that is engaged in the discovery, development, licensing manufacturing, marketing, distribution, and sale of medicines and related medical products to patients with serious diseases. The company's primary focus is on cancer, cardiovascular, immunology, and fibrotic therapeutic projects. The company researches to focus on the discovery and development of novel medicines that address serious diseases in areas of significant...
